BioCina

BioCina operates as an end-to-end global CDMO specializing in process development and cGMP manufacturing of biologics—including microbial-based products, plasmid DNA, mRNA vaccines/drugs with LNP encapsulation capabilities—and sterile fill-finish services. The company supports pharmaceutical and biopharmaceutical clients from early-phase clinical trials through to commercialization. It boasts US FDA-, EMA-, TGA-, and Health Canada-approved facilities in Adelaide and Perth. Over the past 15 years, BioCina has worked on more than 60 different products with over 30 global partners. It does not have its own drug pipeline or clinical results but provides critical infrastructure for the manufacture of advanced therapeutics worldwide.